Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

Check your eligibility now & get in touch with a study center

CHECK ELIGIBILITY

wAIHA?

Warm autoimmune hemolytic anemia (wAIHA) is a rare blood condition, in which: 

  1. Your body attacks its own red blood cells by mistake.
  2. Your red blood cells are destroyed too quickly.
  3. This leads to anemia, which means you don't have enough healthy red blood cells.
  4. You might feel tired, dizzy, or short of breath.
  5. Your heart might beat faster than normal.
  6. It's called "warm" because it happens at your body's normal temperature.
Mountains image

What is the investigational study medication?

The investigational medicine being studied is called rilzabrutinib. It's still being tested, so doctors can't give it to everyone yet. This medicine tries to stop a protein in your body. By doing this, it might help calm your body's defenses and stop them from hurting your blood cells.

What is the purpose of the study?

Topical Agents icon

Help your blood carry more oxygen by increasing and maintaining your hemoglobin levels

Systemic Therapies icon

 

Reduce how often you need blood transfusions and other medicines

Phototherapy icon

 

Make you feel better by improving your symptoms

Phototherapy icon

Lower the number of bad antibodies in your body that are harming your red blood cells

What can you expect during the study? 

At your appointments, we'll do several checks to monitor your health. 

Patient care icon


A physical exam

Innovative treatments icon

An electrocardiogram (EKG), a test that checks your heart's electrical activity using electrodes placed on your skin

Knowledgeable insights icon


Blood and urine tests

Medication trials icon


Questionnaires

FAQs: Frequently asked questions:

How many people are participating in this study?

Approximately 90 adults.

How long is the study?

  • At least one year, with the potential for an additional long-term extension (an additional one year minimum).
  • Approximately 29 onsite study visits initially, each approximately two (2) hours long.

What is a placebo?

A placebo looks like the medicine being tested and is also given in the same way as the medication that is being studied, but it does not have any medicine in it. You have a 2 in 3 chance (66%) of receiving the study medication and a 1 in 3 chance (33%) of receiving a placebo.  If you participate in the study, you would take either the study medication or placebo as a pill twice a day.

Is there a cost to participate?

There is no cost to participate. All study-related exams, study-related medications and study-related medical care are provided. There is no insurance required to take part in this study. You may be compensated for travel.

Find a site near you

Version 1.0

Images property of Sanofi